Literature DB >> 16477341

Seventeen alpha-hydroxylase deficiency.

Siew-Lee Wong1, San-Ging Shu, Chi-Ren Tsai.   

Abstract

Seventeen alpha-hydroxylase deficiency (17OHD) is a rare form of congenital adrenal hyperplasia in which defects in the biosynthesis of cortisol and sex steroid result in mineralocorticoid excess, hypokalemic hypertension and sexual abnormalities such as pseudohermaphroditism in males, and sexual infantilism in females. The disease is inherited in an autosomal recessive pattern, and is caused by mutations in the gene encoding cytochrome P450c17 (CYP17), which is the single polypeptide that mediates both 17alpha-hydroxylase and 17,20-lyase activities. We report the case of a 15-year-old patient with 17OHD who had a female phenotype but male karyotype (46,XY). The diagnosis was made based on classical clinical features, biochemical data and molecular genetic study. Two mutations were identified by polymerase chain reaction amplification and sequencing, including a S106P point mutation in exon 2 and a 9-bp (GACTCTTTC) deletion from nucleotide position 1519 in exon 8 of CYP17. The first of these mutations was found in the father and the second in the mother, and both have been previously reported in Asia. The patient's hypertension and hypokalemia resolved after glucocorticoid replacement and treatment with potassium-sparing diuretics. Sex hormone replacement was prescribed for induction of sexual development and reduction of the final height. Prophylactic gonadectomy was scheduled. In summary, 17OHD should be suspected in patients with hypokalemic hypertension and lack of secondary sexual development so that appropriate therapy can be implemented.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477341     DOI: 10.1016/S0929-6646(09)60342-9

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  8 in total

Review 1.  Congenital adrenal hyperplasia causing hypertension: an illustrative review.

Authors:  Laura Hinz; Daniele Pacaud; Gregory Kline
Journal:  J Hum Hypertens       Date:  2017-12-18       Impact factor: 3.012

2.  Male pseudohermaphroditism as a cause of secondary hypertension: a case report.

Authors:  Zeki Aydin; Savas Ozturk; Meltem Gursu; Sami Uzun; Serhat Karadag; Rumeyza Kazancioglu
Journal:  Endocrine       Date:  2010-06-22       Impact factor: 3.633

Review 3.  Multidisciplinary team management of 46,XY 17α-hydroxylase deficiency: a case report and literature review.

Authors:  Yang Zhou; Xue Xue; Panpan Shi; Qinrui Lu; Shulan Lv
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

4.  Molecular Diagnosis of Congenital Adrenal Hyperplasia in Iran: Focusing on CYP21A2 Gene.

Authors:  Bahareh Rabbani; Nejat Mahdieh; Mohammad-Taghi Haghi Ashtiani; Mohammad-Taghi Akbari; Ali Rabbani
Journal:  Iran J Pediatr       Date:  2011-06       Impact factor: 0.364

5.  CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiency.

Authors:  Daw-Yang Hwang; Chi-Chih Hung; Felix G Riepe; Richard J Auchus; Alexandra E Kulle; Paul-Martin Holterhus; Mei-Chyn Chao; Mei-Chuan Kuo; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

6.  Seventeen Alpha-Hydroxylase Deficiency Associated with Absent Gonads and Myelolipoma: A Case Report and Review of Literature.

Authors:  Mahmood Soveid; Ghanbar Ali Rais-Jalali
Journal:  Iran J Med Sci       Date:  2016-11

7.  17 alpha-hydroxylase deficiency: A case report of young Chinese woman with a rare gene mutation.

Authors:  Li Hui Han; Liang Wang; Xiu Yun Wu
Journal:  Clin Case Rep       Date:  2022-07-25

Review 8.  Reproductive endocrine characteristics and in vitro fertilization treatment of female patients with partial 17α-hydroxylase deficiency: Two pedigree investigations and a literature review.

Authors:  Shutian Jiang; Yue Xu; Jie Qiao; Yao Wang; Yanping Kuang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-14       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.